As of April 2024 Compugen has a market cap of $0.17 Billion. This makes Compugen the world's 7030th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.17 B | -2.73% |
2023 | $0.17 B | 181.64% |
2022 | $62.09 M | -82.69% |
2021 | $0.35 B | -64.18% |
2020 | $1.00 B | 144.93% |
2019 | $0.40 B | 204.1% |
2018 | $0.13 B | 4.88% |
2017 | $0.12 B | -50.83% |
2016 | $0.26 B | -17.67% |
2015 | $0.31 B | -24.62% |
2014 | $0.42 B | 17.33% |
2013 | $0.35 B | 97.67% |
2012 | $0.18 B | 5.47% |
2011 | $0.17 B | -9.65% |
2010 | $0.19 B | 19.28% |
2009 | $0.15 B | 1200.2% |
2008 | $12.26 M | -72.95% |
2007 | $45.31 M | -37.87% |
2006 | $72.94 M | -38.51% |
2005 | $0.11 B | -16.92% |
2004 | $0.14 B | 5.31% |
2003 | $0.13 B | 191.89% |
2002 | $46.45 M | -62.07% |
2001 | $0.12 B |
On Apr 19th, 2024 the market cap of Compugen was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Seagen
SGEN | $43.15 B | 25,269.14% | ๐บ๐ธ USA |
Genetic Technologies GENE | $12.36 M | -92.73% | ๐ฆ๐บ Australia |
Teva Pharmaceutical Industries TEVA | $14.56 B | 8,462.68% | ๐ฎ๐ฑ Israel |
Eterna Therapeutics ERNA | $11.63 M | -93.16% | ๐บ๐ธ USA |